Lisa Boggio to Middle Aged
This is a "connection" page, showing publications Lisa Boggio has written about Middle Aged.
Connection Strength
0.120
-
Coagulopathies associated with lymphoproliferative disorders. Curr Hematol Rep. 2004 Jan; 3(1):1-4.
Score: 0.023
-
High adherence to prophylaxis regimens in haemophilia B patients receiving rIX-FP: Evidence from clinical trials and real-world practice. Haemophilia. 2020 Jul; 26(4):637-642.
Score: 0.018
-
Patient-reported outcomes and joint status across subgroups of US adults with hemophilia with varying characteristics: Results from the Pain, Functional Impairment, and Quality of Life (P-FiQ) study. Eur J Haematol. 2018 Apr; 100 Suppl 1:14-24.
Score: 0.015
-
PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding. Haemophilia. 2017 Nov; 23(6):832-843.
Score: 0.015
-
Clinical and laboratory phenotype variability in type 2M von Willebrand disease. J Thromb Haemost. 2017 08; 15(8):1559-1566.
Score: 0.015
-
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A. Blood. 2016 08 04; 128(5):630-7.
Score: 0.014
-
Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial. Blood. 2016 04 07; 127(14):1761-9.
Score: 0.013
-
Factor VIII inhibitor associated with peginterferon--a follow up. Haemophilia. 2007 Mar; 13(2):213.
Score: 0.007